首页>
外国专利>
METHOD FOR SUPPRESSING SYMPTOM OF PREMENSTRUAL SYNDROME/LATTER LUTEAL PHASE DYSPHORIA DISEASE
METHOD FOR SUPPRESSING SYMPTOM OF PREMENSTRUAL SYNDROME/LATTER LUTEAL PHASE DYSPHORIA DISEASE
展开▼
机译:抑制经前期综合征/后遗期黄体功能障碍疾病症状的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: To obtain a pharmaceutical composition, containing a 2-phenyl-3- aroylbenzothiophene or its salt or solvate as an active ingredient and useful for inhibiting symptoms of premenstrual syndrome/late luteal phase dysphoric disorders. CONSTITUTION: This composition contains a 2-phenyl-3-aroylbenzothiophene represented by formula I [R1 and R3 are each CH3 , a CO-(1-6C alkyl) or a CO-Ar (Ar is phenyl which may be substituted); R2 is pyrrolidino, hexamethyleneimino or piperidino] or its pharmaceutically acceptable salt or solvate as an active ingredient and is capable of inhibiting symptoms of premenstrual syndrome/late luteal phase dysphoric disorders. A compound represented by formula II or its hydrochloride, is especially preferred as the compound represented by formula I. The daily dose of the compound represented by formula I is preferably about 50-600 mg. The pharmaceutical composition is suitable for prophylactic administration.
展开▼
机译:目的:获得包含2-苯基-3-芳酰基苯并噻吩或其盐或溶剂化物作为有效成分并且可用于抑制经前期综合征/黄体晚期烦躁不安症状的药物组合物。组成:该组合物包含由式I表示的2-苯基-3-芳基苯并噻吩[R 1和R 3分别为CH 3,CO-(1-6C烷基)或CO-Ar(Ar为苯基,其中可以代替); R 2为吡咯烷基,六亚甲基亚氨基或哌啶子基或其药学上可接受的盐或溶剂合物作为活性成分,并且能够抑制经前期综合征/黄体晚期烦躁不安的症状。由式II表示的化合物或其盐酸盐特别优选作为由式I表示的化合物。由式I表示的化合物的日剂量优选为约50-600mg。该药物组合物适合于预防性给药。
展开▼